Global Point of Care Molecular Diagnostics Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 205329
  • calendar_today Published On: Oct, 2019
  • file_copy Pages: 138
  • list Pharmaceuticals and Healthcare

Scope of the Report:

The global Point of Care Molecular Diagnostics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Point of Care Molecular Diagnostics.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Point of Care Molecular Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Point of Care Molecular Diagnostics market by product type and applications/end industries.

Market Segment by Companies, this report covers

Myriad Genetics

Cepheid

Illumina Inc.

Abbott

Agilent Technologies Inc.

Hoffmann-La Roche Ltd.

GenePOC Inc.

QIAGEN

Hologic Inc.

Genomic Health

Beckman Coulter Inc

Siemens Healthcare GmbH

DxNA LLC.

Abaxis, Bayer AG,

Johnson & Johnson Services Inc.

Biocartis

Binx Health Inc.

Grifols S.A.

Medtronic

Spartan Bioscience Inc.

Quidel Corporation

bioMérieux SA

Sysmex Corporation

BD

OraSure Technologies Inc.

Bio-Rad Laboratories Inc.

Meridian Bioscience Inc.

Danaher

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Assays and Kits

Instruments or Analyzers

Services and Software

Market Segment by Applications, can be divided into

Respiratory Diseases

Sexually Transmitted Diseases

Hospital-acquired Infection

Oncology

Hepatitis

Others

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.


Table of Contents


1 Point of Care Molecular Diagnostics Market Overview

   1.1 Product Overview and Scope of Point of Care Molecular Diagnostics

   1.2 Classification of Point of Care Molecular Diagnostics by Types

         1.2.1 Global Point of Care Molecular Diagnostics Revenue Comparison by Types (2019-2024)

         1.2.2 Global Point of Care Molecular Diagnostics Revenue Market Share by Types in 2018

         1.2.3 Assays and Kits

         1.2.4 Instruments or Analyzers

         1.2.5 Services and Software

   1.3 Global Point of Care Molecular Diagnostics Market by Application

         1.3.1 Global Point of Care Molecular Diagnostics Market Size and Market Share Comparison by Applications (2014-2024)

         1.3.2 Respiratory Diseases

         1.3.3 Sexually Transmitted Diseases

         1.3.4 Hospital-acquired Infection

         1.3.5 Oncology

         1.3.6 Hepatitis

         1.3.7 Others

   1.4 Global Point of Care Molecular Diagnostics Market by Regions

         1.4.1 Global Point of Care Molecular Diagnostics Market Size (Million USD) Comparison by Regions (2014-2024)

         1.4.1 North America (USA, Canada and Mexico) Point of Care Molecular Diagnostics Status and Prospect (2014-2024)

         1.4.2 Europe (Germany, France, UK, Russia and Italy) Point of Care Molecular Diagnostics Status and Prospect (2014-2024)

         1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Point of Care Molecular Diagnostics Status and Prospect (2014-2024)

         1.4.4 South America (Brazil, Argentina, Colombia) Point of Care Molecular Diagnostics Status and Prospect (2014-2024)

         1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Point of Care Molecular Diagnostics Status and Prospect (2014-2024)

   1.5 Global Market Size of Point of Care Molecular Diagnostics (2014-2024)


2 Company Profiles

   2.1 Myriad Genetics

         2.1.1 Business Overview

         2.1.2 Point of Care Molecular Diagnostics Type and Applications

                  2.1.2.1 Product A

                  2.1.2.2 Product B

         2.1.3 Myriad Genetics Point of Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)

   2.2 Cepheid

         2.2.1 Business Overview

         2.2.2 Point of Care Molecular Diagnostics Type and Applications

                  2.2.2.1 Product A

                  2.2.2.2 Product B

         2.2.3 Cepheid Point of Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)

   2.3 Illumina Inc.

         2.3.1 Business Overview

         2.3.2 Point of Care Molecular Diagnostics Type and Applications

                  2.3.2.1 Product A

                  2.3.2.2 Product B

         2.3.3 Illumina Inc. Point of Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)

   2.4 Abbott

         2.4.1 Business Overview

         2.4.2 Point of Care Molecular Diagnostics Type and Applications

                  2.4.2.1 Product A

                  2.4.2.2 Product B

         2.4.3 Abbott Point of Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)

   2.5 Agilent Technologies Inc.

         2.5.1 Business Overview

         2.5.2 Point of Care Molecular Diagnostics Type and Applications

                  2.5.2.1 Product A

                  2.5.2.2 Product B

         2.5.3 Agilent Technologies Inc. Point of Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)

   2.6 Hoffmann-La Roche Ltd.

         2.6.1 Business Overview

         2.6.2 Point of Care Molecular Diagnostics Type and Applications

                  2.6.2.1 Product A

                  2.6.2.2 Product B

         2.6.3 Hoffmann-La Roche Ltd. Point of Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)

   2.7 GenePOC Inc.

         2.7.1 Business Overview

         2.7.2 Point of Care Molecular Diagnostics Type and Applications

                  2.7.2.1 Product A

                  2.7.2.2 Product B

         2.7.3 GenePOC Inc. Point of Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)

   2.8 QIAGEN

         2.8.1 Business Overview

         2.8.2 Point of Care Molecular Diagnostics Type and Applications

                  2.8.2.1 Product A

                  2.8.2.2 Product B

         2.8.3 QIAGEN Point of Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)

   2.9 Hologic Inc.

         2.9.1 Business Overview

         2.9.2 Point of Care Molecular Diagnostics Type and Applications

                  2.9.2.1 Product A

                  2.9.2.2 Product B

         2.9.3 Hologic Inc. Point of Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)

   2.10 Genomic Health

         2.10.1 Business Overview

         2.10.2 Point of Care Molecular Diagnostics Type and Applications

                  2.10.2.1 Product A

                  2.10.2.2 Product B

         2.10.3 Genomic Health Point of Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)

   2.11 Beckman Coulter Inc

         2.11.1 Business Overview

         2.11.2 Point of Care Molecular Diagnostics Type and Applications

                  2.11.2.1 Product A

                  2.11.2.2 Product B

         2.11.3 Beckman Coulter Inc Point of Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)

   2.12 Siemens Healthcare GmbH

         2.12.1 Business Overview

         2.12.2 Point of Care Molecular Diagnostics Type and Applications

                  2.12.2.1 Product A

                  2.12.2.2 Product B

         2.12.3 Siemens Healthcare GmbH Point of Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)

   2.13 DxNA LLC.

         2.13.1 Business Overview

         2.13.2 Point of Care Molecular Diagnostics Type and Applications

                  2.13.2.1 Product A

                  2.13.2.2 Product B

         2.13.3 DxNA LLC. Point of Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)

   2.14 Abaxis, Bayer AG,

         2.14.1 Business Overview

         2.14.2 Point of Care Molecular Diagnostics Type and Applications

                  2.14.2.1 Product A

                  2.14.2.2 Product B

         2.14.3 Abaxis, Bayer AG, Point of Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)

   2.15 Johnson & Johnson Services Inc.

         2.15.1 Business Overview

         2.15.2 Point of Care Molecular Diagnostics Type and Applications

                  2.15.2.1 Product A

                  2.15.2.2 Product B

         2.15.3 Johnson & Johnson Services Inc. Point of Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)

   2.16 Biocartis

         2.16.1 Business Overview

         2.16.2 Point of Care Molecular Diagnostics Type and Applications

                  2.16.2.1 Product A

                  2.16.2.2 Product B

         2.16.3 Biocartis Point of Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)

   2.17 Binx Health Inc.

         2.17.1 Business Overview

         2.17.2 Point of Care Molecular Diagnostics Type and Applications

                  2.17.2.1 Product A

                  2.17.2.2 Product B

         2.17.3 Binx Health Inc. Point of Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)

   2.18 Grifols S.A.

         2.18.1 Business Overview

         2.18.2 Point of Care Molecular Diagnostics Type and Applications

                  2.18.2.1 Product A

                  2.18.2.2 Product B

         2.18.3 Grifols S.A. Point of Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)

   2.19 Medtronic

         2.19.1 Business Overview

         2.19.2 Point of Care Molecular Diagnostics Type and Applications

                  2.19.2.1 Product A

                  2.19.2.2 Product B

         2.19.3 Medtronic Point of Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)

   2.20 Spartan Bioscience Inc.

         2.20.1 Business Overview

         2.20.2 Point of Care Molecular Diagnostics Type and Applications

                  2.20.2.1 Product A

                  2.20.2.2 Product B

         2.20.3 Spartan Bioscience Inc. Point of Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)

   2.21 Quidel Corporation

         2.21.1 Business Overview

         2.21.2 Point of Care Molecular Diagnostics Type and Applications

                  2.21.2.1 Product A

                  2.21.2.2 Product B

         2.21.3 Quidel Corporation Point of Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)

   2.22 bioMérieux SA

         2.22.1 Business Overview

         2.22.2 Point of Care Molecular Diagnostics Type and Applications

                  2.22.2.1 Product A

                  2.22.2.2 Product B

         2.22.3 bioMérieux SA Point of Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)

   2.23 Sysmex Corporation

         2.23.1 Business Overview

         2.23.2 Point of Care Molecular Diagnostics Type and Applications

                  2.23.2.1 Product A

                  2.23.2.2 Product B

         2.23.3 Sysmex Corporation Point of Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)

   2.24 BD

         2.24.1 Business Overview

         2.24.2 Point of Care Molecular Diagnostics Type and Applications

                  2.24.2.1 Product A

                  2.24.2.2 Product B

         2.24.3 BD Point of Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)

   2.25 OraSure Technologies Inc.

         2.25.1 Business Overview

         2.25.2 Point of Care Molecular Diagnostics Type and Applications

                  2.25.2.1 Product A

                  2.25.2.2 Product B

         2.25.3 OraSure Technologies Inc. Point of Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)

   2.26 Bio-Rad Laboratories Inc.

         2.26.1 Business Overview

         2.26.2 Point of Care Molecular Diagnostics Type and Applications

                  2.26.2.1 Product A

                  2.26.2.2 Product B

         2.26.3 Bio-Rad Laboratories Inc. Point of Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)

   2.27 Meridian Bioscience Inc.

         2.27.1 Business Overview

         2.27.2 Point of Care Molecular Diagnostics Type and Applications

                  2.27.2.1 Product A

                  2.27.2.2 Product B

         2.27.3 Meridian Bioscience Inc. Point of Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)

   2.28 Danaher

         2.28.1 Business Overview

         2.28.2 Point of Care Molecular Diagnostics Type and Applications

                  2.28.2.1 Product A

                  2.28.2.2 Product B

         2.28.3 Danaher Point of Care Molecular Diagnostics Revenue, Gross Margin and Market Share (2017-2018)


3 Global Point of Care Molecular Diagnostics Market Competition, by Players

   3.1 Global Point of Care Molecular Diagnostics Revenue and Share by Players (2014-2019)

   3.2 Market Concentration Rate

         3.2.1 Top 5 Point of Care Molecular Diagnostics Players Market Share

         3.2.2 Top 10 Point of Care Molecular Diagnostics Players Market Share

   3.3 Market Competition Trend


4 Global Point of Care Molecular Diagnostics Market Size by Regions

   4.1 Global Point of Care Molecular Diagnostics Revenue and Market Share by Regions

   4.2 North America Point of Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)

   4.3 Europe Point of Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)

   4.4 Asia-Pacific Point of Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)

   4.5 South America Point of Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)

   4.6 Middle East and Africa Point of Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)


5 North America Point of Care Molecular Diagnostics Revenue by Countries

   5.1 North America Point of Care Molecular Diagnostics Revenue by Countries (2014-2019)

   5.2 USA Point of Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)

   5.3 Canada Point of Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)

   5.4 Mexico Point of Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)


6 Europe Point of Care Molecular Diagnostics Revenue by Countries

   6.1 Europe Point of Care Molecular Diagnostics Revenue by Countries (2014-2019)

   6.2 Germany Point of Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)

   6.3 UK Point of Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)

   6.4 France Point of Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)

   6.5 Russia Point of Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)

   6.6 Italy Point of Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)


7 Asia-Pacific Point of Care Molecular Diagnostics Revenue by Countries

   7.1 Asia-Pacific Point of Care Molecular Diagnostics Revenue by Countries (2014-2019)

   7.2 China Point of Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)

   7.3 Japan Point of Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)

   7.4 Korea Point of Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)

   7.5 India Point of Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)

   7.6 Southeast Asia Point of Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)


8 South America Point of Care Molecular Diagnostics Revenue by Countries

   8.1 South America Point of Care Molecular Diagnostics Revenue by Countries (2014-2019)

   8.2 Brazil Point of Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)

   8.3 Argentina Point of Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)

   8.4 Colombia Point of Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)


9 Middle East and Africa Revenue Point of Care Molecular Diagnostics by Countries

   9.1 Middle East and Africa Point of Care Molecular Diagnostics Revenue by Countries (2014-2019)

   9.2 Saudi Arabia Point of Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)

   9.3 UAE Point of Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)

   9.4 Egypt Point of Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)

   9.5 Nigeria Point of Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)

   9.6 South Africa Point of Care Molecular Diagnostics Revenue and Growth Rate (2014-2019)


10 Global Point of Care Molecular Diagnostics Market Segment by Type

   10.1 Global Point of Care Molecular Diagnostics Revenue and Market Share by Type (2014-2019)

   10.2 Global Point of Care Molecular Diagnostics Market Forecast by Type (2019-2024)

   10.3 Assays and Kits Revenue Growth Rate (2014-2024)

   10.4 Instruments or Analyzers Revenue Growth Rate (2014-2024)

   10.5 Services and Software Revenue Growth Rate (2014-2024)


11 Global Point of Care Molecular Diagnostics Market Segment by Application

   11.1 Global Point of Care Molecular Diagnostics Revenue Market Share by Application (2014-2019)

   11.2 Point of Care Molecular Diagnostics Market Forecast by Application (2019-2024)

   11.3 Respiratory Diseases Revenue Growth (2014-2019)

   11.4 Sexually Transmitted Diseases Revenue Growth (2014-2019)

   11.5 Hospital-acquired Infection Revenue Growth (2014-2019)

   11.6 Oncology Revenue Growth (2014-2019)

   11.7 Hepatitis Revenue Growth (2014-2019)

   11.8 Others Revenue Growth (2014-2019)


12 Global Point of Care Molecular Diagnostics Market Size Forecast (2019-2024)

   12.1 Global Point of Care Molecular Diagnostics Market Size Forecast (2019-2024)

   12.2 Global Point of Care Molecular Diagnostics Market Forecast by Regions (2019-2024)

   12.3 North America Point of Care Molecular Diagnostics Revenue Market Forecast (2019-2024)

   12.4 Europe Point of Care Molecular Diagnostics Revenue Market Forecast (2019-2024)

   12.5 Asia-Pacific Point of Care Molecular Diagnostics Revenue Market Forecast (2019-2024)

   12.6 South America Point of Care Molecular Diagnostics Revenue Market Forecast (2019-2024)

   12.7 Middle East and Africa Point of Care Molecular Diagnostics Revenue Market Forecast (2019-2024)


13 Research Findings and Conclusion


14 Appendix

   14.1 Methodology

   14.2 Data Source



List of Tables and Figures

Figure Point of Care Molecular Diagnostics Picture

Table Product Specifications of Point of Care Molecular Diagnostics

Table Global Point of Care Molecular Diagnostics and

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery